Paul Brannelly
2019 - Collegium Pharmaceutical
In 2019, Paul Brannelly earned a total compensation of $1.7M as Executive Vice President and Chief Financial Officer at Collegium Pharmaceutical, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $214,800 |
|---|---|
| Option Awards | $305,685 |
| Salary | $413,077 |
| Stock Awards | $763,200 |
| Other | $17,012 |
| Total | $1,713,774 |
Brannelly received $763.2K in stock awards, accounting for 45% of the total pay in 2019.
Brannelly also received $214.8K in non-equity incentive plan, $305.7K in option awards, $413.1K in salary and $17K in other compensation.
Rankings
In 2019, Paul Brannelly's compensation ranked 6,675th out of 13,971 executives tracked by ExecPay. In other words, Brannelly earned more than 52.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,675 out of 13,971 | 52nd |
Division Manufacturing | 2,542 out of 5,695 | 55th |
Major group Chemicals And Allied Products | 924 out of 2,194 | 58th |
Industry group Drugs | 781 out of 1,880 | 59th |
Industry Pharmaceutical Preparations | 574 out of 1,392 | 59th |
Source: SEC filing on April 9, 2020.
Brannelly's colleagues
We found four more compensation records of executives who worked with Paul Brannelly at Collegium Pharmaceutical in 2019.